RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cassava Sciences Stock

Cassava Sciences ROE 2025

Cassava Sciences ROE

-0.17

Ticker

SAVA

ISIN

US14817C1071

WKN

A2PGL8

In 2025, Cassava Sciences's return on equity (ROE) was -0.17, a -76.38% increase from the -0.71 ROE in the previous year.

Cassava Sciences Aktienanalyse

What does Cassava Sciences do?

Cassava Sciences Inc. is a biotechnology company founded in 1998. Its headquarters is in Austin, Texas. The company aims to research the inflammatory causes of neurodegenerative diseases, such as Alzheimer's, and develop new treatment options and medications. Cassava Sciences' business model is based on the development and commercialization of innovative therapies through research, clinical trials, and partnerships with other companies. The company focuses on developing treatment options for Alzheimer's disease. Cassava Sciences consists of various divisions that work closely together. One focus of the company is researching and developing new medications for the treatment of Alzheimer's. The company collaborates closely with scientists to develop new treatment options. Another important aspect of Cassava Sciences is conducting clinical trials to test the effectiveness and safety of the developed medications. The company collaborates with globally renowned research institutions. One of Cassava Sciences' products is the medication PTI-125, which was developed for the treatment of Alzheimer's. The medication aims to target the inflammatory causes of the disease and slow down its progression. PTI-125 is currently in Phase IIb of clinical testing and shows promising results. In recent years, Cassava Sciences has formed several partnerships with other companies to advance research and development of new treatment options. For example, the company collaborates with Pfizer and AbbVie. The history of Cassava Sciences is marked by intensive research activity and the goal of improving the quality of life for people with Alzheimer's disease. The company's research findings have been presented at scientific conferences and received significant media attention. In summary, Cassava Sciences is an innovative biotechnology company focused on researching and developing treatment options for Alzheimer's. In addition to developing new medications, the company also conducts clinical trials and collaborates with other companies to advance research. Cassava Sciences sees itself as a pioneer in the field of Alzheimer's therapy and aims to significantly improve the quality of life for people with this condition. Cassava Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Cassava Sciences's Return on Equity (ROE)

Cassava Sciences's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Cassava Sciences's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Cassava Sciences's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Cassava Sciences’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Cassava Sciences stock

What is the ROE (Return on Equity) of Cassava Sciences this year?

The ROE of Cassava Sciences this year is -0.17 undefined.

How has the Return on Equity (ROE) of Cassava Sciences developed compared to the previous year?

The ROE of Cassava Sciences has increased by -76.38% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Cassava Sciences?

A high ROE indicates that Cassava Sciences generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Cassava Sciences?

A low ROE can indicate that Cassava Sciences is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Cassava Sciences affect the company?

A change in ROE (Return on Equity) of Cassava Sciences can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Cassava Sciences?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Cassava Sciences?

Some factors that can influence Cassava Sciences's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Cassava Sciences pay?

Over the past 12 months, Cassava Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cassava Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Cassava Sciences?

The current dividend yield of Cassava Sciences is .

When does Cassava Sciences pay dividends?

Cassava Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cassava Sciences?

Cassava Sciences paid dividends every year for the past 0 years.

What is the dividend of Cassava Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cassava Sciences located?

Cassava Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cassava Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cassava Sciences from 12/24/2012 amounting to 0.75 USD, you needed to have the stock in your portfolio before the ex-date on 12/13/2012.

When did Cassava Sciences pay the last dividend?

The last dividend was paid out on 12/24/2012.

What was the dividend of Cassava Sciences in the year 2024?

In the year 2024, Cassava Sciences distributed 0 USD as dividends.

In which currency does Cassava Sciences pay out the dividend?

The dividends of Cassava Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Cassava Sciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Cassava Sciences

Our stock analysis for Cassava Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cassava Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.